Loading...
XJPX9267
Market cap592mUSD
Jan 15, Last price  
3,045.00JPY
1D
2.01%
1Q
-11.22%
Jan 2017
8.17%
IPO
-27.33%
Name

Genky DrugStores Co Ltd

Chart & Performance

D1W1MN
XJPX:9267 chart
P/E
14.64
P/S
0.50
EPS
208.05
Div Yield, %
0.41%
Shrs. gr., 5y
-0.30%
Rev. gr., 5y
12.21%
Revenues
184.86b
+9.35%
32,728,548,00036,925,598,00041,247,851,00051,516,890,00056,700,822,00054,656,383,00057,949,841,00063,143,693,00073,495,982,00083,399,634,00094,869,235,000103,897,310,000123,603,493,000142,376,114,000154,639,641,000169,059,000,000184,860,000,000
Net income
6.32b
+32.75%
900,726,000480,204,000656,095,000904,224,0001,144,188,000623,065,0001,171,132,0001,761,329,0001,901,352,0002,845,744,0003,118,297,0002,697,564,0002,755,024,0004,831,655,0004,420,000,0004,764,000,0006,324,000,000
CFO
13.26b
+51.10%
1,741,590,0001,953,309,0001,361,342,0002,897,451,0001,204,516,000542,485,0003,662,754,0004,758,168,0002,695,936,0005,238,675,0005,365,353,0004,300,287,0007,411,057,00012,075,282,0006,076,279,0008,773,000,00013,256,000,000
Dividend
Jun 19, 20250 JPY/sh

Profile

Genky DrugStores Co., Ltd. operates a chain of drug stores. The company was founded in 1988 and is headquartered in Sakai, Japan.
URL
http://www.genky.co.jp/
IPO date
Dec 21, 2017
Employees
1,710
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
184,860,000
9.35%
169,059,000
9.32%
154,639,641
8.61%
Cost of revenue
147,239,000
134,505,000
123,685,308
Unusual Expense (Income)
NOPBT
37,621,000
34,554,000
30,954,333
NOPBT Margin
20.35%
20.44%
20.02%
Operating Taxes
2,478,000
1,939,000
1,663,102
Tax Rate
6.59%
5.61%
5.37%
NOPAT
35,143,000
32,615,000
29,291,231
Net income
6,324,000
32.75%
4,764,000
7.78%
4,420,000
-8.52%
Dividends
(380,000)
(379,000)
(379,418)
Dividend yield
0.43%
0.28%
0.37%
Proceeds from repurchase of equity
27,000
11,033,000
12,902
BB yield
-0.03%
-8.25%
-0.01%
Debt
Debt current
8,095,000
11,261,000
10,197,581
Long-term debt
22,705,000
21,259,000
20,789,160
Deferred revenue
(1,006,000)
(516,964)
Other long-term liabilities
3,861,000
4,023,000
2,473,306
Net debt
21,144,000
23,554,000
21,868,477
Cash flow
Cash from operating activities
13,256,000
8,773,000
6,076,279
CAPEX
(10,278,000)
(9,928,000)
(10,507,684)
Cash from investing activities
(10,631,000)
(9,736,000)
(10,588,818)
Cash from financing activities
(2,058,000)
854,000
2,037,507
FCF
29,897,000
26,544,289
22,558,558
Balance
Cash
5,896,000
5,329,000
5,438,264
Long term investments
3,760,000
3,637,000
3,680,000
Excess cash
413,000
513,050
1,386,282
Stockholders' equity
41,029,000
75,607,000
30,599,674
Invested Capital
80,775,000
74,498,950
66,800,078
ROIC
45.27%
46.16%
47.36%
ROCE
46.34%
45.46%
45.06%
EV
Common stock shares outstanding
30,416
30,390
30,396
Price
2,882.00
-34.50%
4,400.00
30.95%
3,360.00
-13.40%
Market cap
87,659,748
-34.44%
133,716,686
30.93%
102,129,088
-13.37%
EV
108,803,748
197,834,686
123,997,565
EBITDA
43,187,000
39,509,000
35,546,411
EV/EBITDA
2.52
5.01
3.49
Interest
103,000
70,000
59,090
Interest/NOPBT
0.27%
0.20%
0.19%